Breaking point: Systemic mastocytosis manifesting as severe osteoporosis.

Oncoscience Pub Date : 2025-02-04 eCollection Date: 2025-01-01 DOI:10.18632/oncoscience.614
Areti Kalfoutzou, Kalliroi Spanou, Adam Mylonakis, Vassiliki Lagopoulou, Maria Dimitrakoudi, Alexandra Korovila, Christos Piperis, Eleni Tsiouri, Eleni Mostratou
{"title":"Breaking point: Systemic mastocytosis manifesting as severe osteoporosis.","authors":"Areti Kalfoutzou, Kalliroi Spanou, Adam Mylonakis, Vassiliki Lagopoulou, Maria Dimitrakoudi, Alexandra Korovila, Christos Piperis, Eleni Tsiouri, Eleni Mostratou","doi":"10.18632/oncoscience.614","DOIUrl":null,"url":null,"abstract":"<p><p>Systemic mastocytosis (SM) encompasses a wide spectrum of myeloproliferative disorders defined by the aggregation of abnormal mast cells in various tissues, including the bone marrow, gastrointestinal tract, liver and lymph nodes. The release of tryptase, interleukins and cytokines by the accumulated mast cells causes a multi-system response that can range from mild flushing and pruritus to severe anaphylactic reactions, gastrointestinal disturbances, and cardiovascular symptoms, including hypotension and syncope. Furthermore, severe osteoporosis manifesting as bone-lytic lesions or pathologic fractures due to mast cell mediator-triggered bone resorption, is a rather common manifestation of SM, occurring in more than two-thirds of patients. The vast majority of SM cases harbor the D816V KIT mutation, which is an independent prognostic factor, and serves as a therapeutic target. This is a rare case of a young male who presented with new-onset back pain due to osteoporotic fractures and was diagnosed with SM without the D816V KIT mutation. Our case aims to emphasize one of the most underrecognised causes of osteoporosis in adults, and to shed light on a frequently misdiagnosed yet potentially severe hematologic disorder.</p>","PeriodicalId":94164,"journal":{"name":"Oncoscience","volume":"12 ","pages":"13-20"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11796133/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncoscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18632/oncoscience.614","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Systemic mastocytosis (SM) encompasses a wide spectrum of myeloproliferative disorders defined by the aggregation of abnormal mast cells in various tissues, including the bone marrow, gastrointestinal tract, liver and lymph nodes. The release of tryptase, interleukins and cytokines by the accumulated mast cells causes a multi-system response that can range from mild flushing and pruritus to severe anaphylactic reactions, gastrointestinal disturbances, and cardiovascular symptoms, including hypotension and syncope. Furthermore, severe osteoporosis manifesting as bone-lytic lesions or pathologic fractures due to mast cell mediator-triggered bone resorption, is a rather common manifestation of SM, occurring in more than two-thirds of patients. The vast majority of SM cases harbor the D816V KIT mutation, which is an independent prognostic factor, and serves as a therapeutic target. This is a rare case of a young male who presented with new-onset back pain due to osteoporotic fractures and was diagnosed with SM without the D816V KIT mutation. Our case aims to emphasize one of the most underrecognised causes of osteoporosis in adults, and to shed light on a frequently misdiagnosed yet potentially severe hematologic disorder.

突破点:全身性肥大细胞增多症表现为严重骨质疏松症。
系统性肥大细胞增多症(SM)包括广泛的骨髓增生性疾病,由异常肥大细胞聚集在各种组织中定义,包括骨髓、胃肠道、肝脏和淋巴结。积聚的肥大细胞释放胰蛋白酶、白细胞介素和细胞因子引起多系统反应,从轻度潮红和瘙痒到严重的过敏反应、胃肠道紊乱和心血管症状,包括低血压和晕厥。此外,严重骨质疏松症表现为骨质溶解病变或病理性骨折,由肥大细胞介质引发的骨吸收,是一个相当常见的SM的表现,发生在超过三分之二的患者。绝大多数SM病例携带D816V KIT突变,这是一个独立的预后因素,可作为治疗靶点。这是一例罕见的年轻男性,由于骨质疏松性骨折而出现新发背痛,并被诊断为SM,没有D816V KIT突变。我们的病例旨在强调成人骨质疏松症最不被认识的原因之一,并阐明一种经常误诊但潜在严重的血液系统疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信